Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. Click Therapeutics™ digital interventions enable change within individuals, and can be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to drive cognitive and behavioral outcomes. As the leader in Digital Therapeutics solutions, Click Therapeutics is building the brains behind digital health.
What We Do
Our analysts identify opportunities in which digital therapeutics can significantly impact clinical and economic outcomes for high-risk populations.
Our team of medical doctors and scientists research and recommend the best, clinically validated methods of addressing the opportunity.
Our user experience and design team masterfully create a beautiful and engaging application.
Our engineering team makes it work, seamlessly and scalably.
Our data scientists author rigorous statistical algorithms that adapt our therapeutic mechanisms to each user’s particular neurological profile.
We work with leading academic institutions to pilot and prove significant clinical and economic benefit.
We customize and integrate the application to fit within our partner’s existing infrastructure, and provide success-only billing based on improved outcomes. Our partners are provided with a real-time data analytics portal including metrics on engagement, behavior changes, endpoint achievement, and ROI based on projected and realized cost savings.
Everyone Wins. Patients win by gaining access to more effective treatments, and our partners win by increasing profits and improving clinical outcomes
Payers reduce healthcare spend and increase profits by optimizing health maintenance and disease prevention across covered lives.
Health care providers deliver more effective and efficient care to their patients while enhancing morbidity and mortality outcomes.
Pharmaceutical companies augment effect size, increase patient share, improve adherence, and de-risk drug development initiatives.
CT-100: CLICK Neurobehavioral Intervention (CNI) Platform
Smoking Cessation
Myocardial Infarction
Chronic Pain
Depressed Mood
Major Depressive Disorder
Clinical trial of Clickotine, a digital therapeutics solution for smoking cessation: design and telehealth execution methodology

Steinerman et al. (2016)
CNS Summit

Clickotine, a personalized smartphone app for smoking cessation: initial evaluation

Iacoviello et al. (2017)
JMIR mHealth and uHealth

Six-month outcomes from Clickotine: a digital therapeutic program for smoking cessation

Iacoviello et al. (2017)
Society for Research on Nicotine and Tobacco

Self-reported depression and anxiety during a smoking cessation quit-aid trial

Saleem et al. (2017)
Association for Psychological Science

Cognitive-emotional training as an intervention for major depressive disorder

Iacoviello et al. (2014)
Depression and Anxiety

Developing cognitive-emotional training exercises as interventions for mood and anxiety disorders

Iacoviello et al. (2015)
European Psychiatry

Neuroscience-informed cognitive-affective training interventions for mood and anxiety disorders

Alvarez et al. (2015)
Current Treatment Options in Psychiatry

Evaluating the efficacy of a cognitive-emotional training Intervention for depression

Hoch et al. (2017)
Society of Biological Psychiatry

David B. Klein
Chief Executive Officer
Victor Gao
Chief Innovation Officer
Wei Zhou
Chief Experience Officer
Ted Silver
Chief Financial Officer
Joel Sangerman
Chief Commercial Officer
Christopher Jordan
Chief Technology Officer
Brian Iacoviello, PhD
Director of Scientific Affairs
Michael Ng
Director of Engineering
Jacob Choi
Design Director
Hannar Lee
Daniel Shin
Data Scientist
Matthew Springer
Liz Germana, LCSW
Community Manager
Sarah Jackson
Joshua Steinerman, MD
Chief Neuroscientist
Bruce Leuchter, MD
Senior Advisor
Nik Schork, PhD
Jonathan Sporn, M.D.
Scientific Advisor
Seth Feuerstein, MD
Sean Luo, MD, PhD
Scientific Advisor
Maria Forero
Strategic Advisor
Meir Kryger, MD
Senior Scientific Advisor
Barry Fine, MD, PhD
Scientific Advisor
Gina Kruse, MD
Scientific Advisor
Adam Berger
Technology Advisor
Tavis Allison
Grants Advisor
David Benshoof Klein
Executive Chairman, Interim President & CEO
  • Former Managing Director of Opus Point & Co., a hedge fund and private equity firm dedicated to life science investing
  • 14+ years life science industry experience; key roles in founding, developing and financing >10 life science companies
  • Co-Founder and Owner of Klein Sun Gallery, America's leading Chinese contemporary art gallery
  • Guest Lecturer, Columbia University Biotechnology Program
  • Former Senior Consultant to Pfizer and Strategic Advisor to publicly traded and privately held life science companies
  • B.A., Brandeis University
Victor Gao
Vice Chairman, Chief Innovation & Engagement Officer
  • Former Senior VP at Cerberus Capital Management, Structured Products Trading
  • Former VP at Bear Stearns, Financial Analytics & Structured Transactions Group
  • Former Associate at Credit Suisse, Credit Derivative Structuring
  • Former Chief Technology Officer, (later
  • B.A., Cum Laude, Biochemistry & Computational Neuroscience, Harvard University
Wei Zhou
Chief Experience Officer
  • Former Partner & Head of Product for &
  • Former UX / Art Director at Isobar
  • Former User Experience Designer at Microsoft & Mozilla
  • Significant experience leading the design of mobile healthcare applications
  • MFA, Graphic Design, Yale University; MDes, Interaction Design, Carnegie Mellon University; B.A/S., Animation & Multimedia/Computer Science, Tsinghua University (#1 in Chinese National Entrance Exam)
Ted Silver, CMA
Chief Financial Officer
  • Former Senior Medical Technology Analyst at Visium Asset Management
  • Former Section Head, Medical Technology at Amaranth Advisors
  • Former Equity Research Associate, Medical Technology at Pequot Capital
  • MBA, Yale University; B.A., Swarthmore College
Joel Sangerman
Chief Commercial Officer
  • Former VP of Sales, Managed Markets at Zillion Health
  • Former Area VP of Sales, Market Development at Walgreens Infusion Services / Option Care
  • Former Director of Payor Relations, Managed Markets, Reimbursement at Johnson & Johnson
  • Former Director of Reimbursement at Cell Therapeutics, Inc
  • Former National Account Manager, Managed Markets at Aventis Pharmaceuticals
  • B.S., Cum Laude, Marketing, DePaul University
Christopher Jordan
Chief Technology Officer
  • Former Engineering Manager at Bloomberg LP
  • Former Senior Team Lead at Bloomberg LP, Research & Development
  • Former Developer at Bloomberg LP
  • B.S.E., Computer Engineering, University of Michigan Ann Arbor
Brian Iacoviello, PhD
Director of Scientific Affairs
  • Assistant Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
  • Former Director of Psychotherapy Research in the Mood and Anxiety Disorders Program at Mount Sinai
  • Conducting over $1M in NIH and foundation-funded research investigating neurobehavioral interventions for mood and anxiety disorders
  • Former Visiting Lecturer at Princeton University and Adjunct Instructor at Temple University
  • Ph.D. and M.A., Clinical Psychology, Temple University; B.A. with Honors, Psychology and Entrepreneurship & Management, Johns Hopkins University
Michael Ng
Director of Engineering
  • Former Senior iOS Developer at Paperless Post
  • Former Software Engineer at SocialFlow
  • Former Software Engineer at UBS
  • B.A., Computer Science & Philosophy, Amherst College
Jacob Seokhoon Choi
Design Director
  • Former Visual Designer, Victoria Productions
  • Former Senior UI Designer, HUMAX
  • Winner, IF Design Award; Silver, IDEA (International Design Excellence Awards); Finalist, Adobe Design Achievement Award; Grand Prize, The Symbol of Korea Design Award
  • B.A., Graphic Design, Kookmin University
Hannar Lee
  • Former iOS Developer at CREAM Style
  • Former Research Assistant, NYU Wireless
  • Former HHC 2nd Battalion, 9th Infantry Regiment, Korean Augmentation to the U.S. Army Scout
  • B.A., Computer Science & Mathematics, New York University
Daniel Shin
Data Scientist
  • Former Data Scientist at IBM
  • Former Data Science Fellow at Metis
  • Former Researcher at Weill Cornell Medical College & NYU Langone Medical Center
  • B.A., Biochemistry, New York University
Matthew Springer
  • Former Software Engineer at Geonetics, Inc.
  • Former Assistant Project Estimator at Barletta Engineering Co.
  • Former Assistant Project Engineer at Consigli Construction
  • B.S., Computer Science, Northeastern University
Liz Germana, LCSW
Community Manager
  • Former Clinical Consultant / Outpatient Therapist at Adaptive Behavioral Services
  • Former Clinical Social Worker at Children’s Hospital of Pittsburgh of UPMC
  • Former Behavioral Specialist Consultant and Mobile Therapist at Youth Advocate Programs, Inc.
  • MSW, University of Pittsburgh; B.A., Indiana University of Pennsylvania
Sarah Jackson
  • Former eCHART Training Coordinator at Erlanger Health System
  • Former Research Assistant, Daniel Gilbert Lab at Harvard University
  • Former Research Assistant, Sidanius Lab in Intergroup Relations at Harvard University
  • B.A., Cum Laude, Cognitive Neuroscience & Evolutionary Psychology, Harvard University
Joshua R. Steinerman, M.D.
Chief Neuroscientist
  • Founder of ProGevity Neuroscience
  • Senior Director at Teva Pharmaceuticals
  • Former Assistant Professor of Neurology at Albert Einstein College of Medicine
  • Completed Neurology residency at Yale School of Medicine; Cognitive Neuropsychiatry fellowship at Columbia University Medical Center
  • M.D., SUNY-Downstate College of Medicine; A.B., Magna Cum Laude, Harvard University
Bruce Leuchter, M.D.
Senior Advisor
  • Managing Director at PJT Partners
  • Assistant Professor of Psychiatry, Weill Cornell Medical College
  • Former Director, Healthcare Investment Banking at Credit Suisse
  • Former Director, Clinical Neuropsychiatry, Weill Cornell Medical College
  • Former Biotechnology Analyst, Global Investment Research at Goldman Sachs & Company
  • M.D., Wayne State University School of Medicine; B.A., with Honors and High Distinction, University of Michigan
Nicholas J. Schork, Ph.D.
Director & Senior Scientific Advisor
  • Professor and Director of Human Biology at the J. Craig Venter Institute; Member, Board of Directors at MD Revolution; Adjunct Professor of Psychiatry and Family and Preventative Medicine at UCSD
  • Former Director of Biostatistics and Bioinformatics at Scripps Translational Science Institute; Former Director of Research at Scripps Genomic Medicine
  • Former Professor of Biostatistics and Psychiatry and Co-Director of the Center for Human Genetics and Genomics at UCSD
  • Former Associate Professor of Epidemiology and Biostatistics at Case Western Reserve University
  • Former Adjunct Associate Professor of Biostatistics at Harvard University
  • Ph.D., Epidemiology, University of Michigan; M.A., Statistics, University of Michigan; M.A. and B.A., Philosophy, University of Michigan
Jonathan Sporn, MD
Scientific Advisor
  • Founder of Perception Neuroscience, a biotechnology company developing novel, fast-acting antidepressants
  • Former Senior Director at Pfizer
  • Former Associate Director, Neurology and Psychiatry, Pharmaceutical Research and Development at Johnson & Johnson
  • Former Senior Clinical Fellow, Mood and Anxiety Disorder Program at National Institute of Mental Health
  • Former Clinical Associate, Psychiatry and Research at Massachusetts General Hospital
  • M.D., University of Miami Medical School; B.S., Zoology, Duke University
Seth Feuerstein, MD
Director & Senior Advisor
  • Chief Medical/Innovation Officer at Magellan Health
  • Founded and sold Cobalt Therapeutics, a premier cognitive behavioral therapy software company
  • Psychiatrist, Connecticut Department of Mental Health and Addiction Services in the Office of Forensic Evaluations
  • Assistant Clinical Professor, Department of Psychiatry, Yale University School of Medicine; Advisory Board Member, Center for Biomedical Interventional Technology, Yale University
  • Former Board of Directors of HistoRx; Former President and CEO of Carigent Therapeutics; Former Principal and Co-Founder of Elm Street Ventures
  • J.D. and M.D., New York University; B.S., Biology, Cornell University
Sean X. Luo, M.D., Ph.D.
Scientific Advisor
  • Leon Levy Fellow, Division of Substance Abuse, Columbia University
  • Significant prior experience in developing Precision Medicine solutions for substance use disorders
  • Completed residency in Psychiatry at Columbia University and the New York State Psychiatric Institute
  • M.D., Columbia University College of Physicians and Surgeons; Ph.D., Computational Neuroscience and Machine Learning, Columbia University; B.A., University of Chicago
Maria Forero
Board Observer & Strategic Advisor
  • Principal & General Partner at Ridgetop Health (former Aelius Healthcare Innovations Fund)
  • Former Head of Sales & Marketing for Sandoz Latin America
  • Former CEO/GM of Spain & Portugal at Novartis Vaccines & Diagnostics
  • Former Vice President, Global Healthcare Marketing Analyst at Morgan Stanley
  • Former Audit Manager at PwC
  • MPH, Columbia University; BSc, Human Genetics, University College London
Meir Kryger, MD
Senior Scientific Advisor
  • Former President of the National Sleep Foundation, the American Academy of Sleep Medicine and the Canadian Sleep Society
  • Chief Editor of the most widely used sleep medicine textbook, The Principles and Practice of Sleep Medicine
  • Program Director and Professor of Pulmonary, Critical Care & Sleep Medicine at Yale School of Medicine; Former Professor of Medicine at the University of Manitoba
  • Physician at the VA Connecticut Health System; Former Director of Research and Education at Gaylord Sleep Medicine
  • M.D., McGill University; B.Sc., McGill University
Barry Fine, MD, PhD
Scientific Advisor
  • Associate Professor of Medicine, Cardiology and Post-Doctoral Research Fellow, Laboratory for Stem Cell Regeneration at Columbia University Medical Center
  • Clinical Fellow, Cardiovascular Medicine at New York Presbyterian Hospital
  • Completed residency in Internal Medicine at New York Presbyterian Hospital
  • MD, Columbia University College of Physicians and Surgeons; PhD, Columbia University; BS, cum laude and Distinction, Yale University
Gina Kruse, MD
Scientific Advisor
  • Assistant Professor of Medicine, Massachusetts General Hospital
  • Assistant Professor at Harvard Medical School
  • Investigator, Tobacco Research and Treatment Center at Harvard Medical School
  • M.D., Baylor College of Medicine; M.P.H., Harvard University School of Public Health; M.S., Health Services Research,Texas Tech University; B.S., Animal Sciences, Iowa State University
Adam Berger
Director of Data Engineering
  • Engineering Manager at Uber
  • Former Director of Data Engineering at Click Therapeutics
  • Former Team Lead at Bloomberg LP, Machine Learning
  • Former Developer at Bloomberg LP, Analytics & Infrastructure
  • Founder at ezbds LLC
  • B.S., Cum Laude, Computer Science & Economics, Washington University in St Louis
Tavis Allison
Grants Advisor
  • Former Director of Strategic Initiatives at Sinai AppLab
  • Former Consultant at Responsive Health
  • Former Program Manager at Mount Sinai Health System
  • Former Director of Grant Development at Mount Sinai School of Medicine
  • M.Sc., Protection Management, John Jay College at CUNY; ABD, Neuroscience, University of California at Los Angeles; B.A., Cognitive Science, Hampshire College
Click Therapeutics, Inc.
Office: (646) 844-2158
For more information, please email:
For career inquiries, please send your CV to: